In accordance with the recognized role of CD44 as a stem cell marker [29,30], few studies particularly established a relationship between TF expression and CSC phenotypes/signatures (CD133+, CD44+) in different cell lines, and the functional role of TF in providing tumor cells with stemness potential has also been reported [48,49,50,51,52]. The gene discussed is PROM1; the disease is neoplasm.